All In Biotech

Free tool

FAERS Monitor: Nplate

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming BLA 125268 or its brand name (Nplate, Romiplostim). Reports on generic versions are filed under their own applications.

Reports

15,183

Serious

11,695

77% of reports

Hospitalization

3,943

Death reported

2,656

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • platelet count decreased1,778
  • drug ineffective1,768
  • off label use1,282
  • thrombocytopenia1,048
  • death1,016
  • platelet count abnormal962
  • therapeutic response decreased942
  • headache616
  • fatigue478
  • platelet count increased404
  • hospitalisation393
  • haemorrhage391
  • arthralgia357
  • nausea351
  • product storage error345

Reports by year received

View as table
YearReports
200847
2009410
20101,850
20112,054
2012891
2013527
2014630
2015799
2016616
2017982
20181,124
2019612
2020522
2021536
2022605
2023826
2024790
2025687
2026675

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,038,976 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
platelet count abnormalSignal962261.9245.0210,155
platelet count increasedSignal40444.340.116,526
platelet count decreasedSignal1,77823.522.537,805
therapeutic response decreasedSignal94221.820.518,481
thrombocytopeniaSignal1,04813.112.311,649
product storage errorSignal3455.54.91,258
haemorrhageSignal3915.24.71,323
hospitalisationSignal3933.53.2721
off label useSignal1,2822.01.9697
drug ineffective1,7681.91.8747
death1,0161.61.5260
headache6161.41.360
arthralgia3571.21.111
fatigue4780.90.813
nausea3510.60.688

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.